HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Clinical and prognostic role of plasma coagulation factor XIII activity for bleeding disorders and 6-year survival in patients with chronic liver disease.

AbstractBACKGROUND/AIMS:
Alterations of plasma coagulation factor XIII may contribute to bleeding disorders in patients with liver cirrhosis. As standard clotting tests such as prothrombin time or activated thromboplastin time (aPTT) cannot detect factor XIII deficiency, this may often be overlooked in clinical practice. We aimed to define factor XIII's clinical and prognostic role in chronic liver disease.
PATIENTS AND METHODS:
Factor XIII activities were assessed among various other parameters in 111 patients with chronic liver diseases during evaluation for liver transplantation in a prospective study.
RESULTS:
Unlike coagulation factors II, V or VII, factor XIII activity was maintained in the majority of patients with liver cirrhosis. However, although rarely, factor XIII deficiencies (<50%) occurred, especially in Child C cirrhosis. Factor XIII levels correlated with liver's biosynthetic capacity (cholinesterase activity, albumin, total protein) as well as with platelet count, global coagulation tests and other single coagulation factors. Patients reporting a current systemic bleeding tendency at study entry had significantly reduced factor XIII. In a 6-year follow-up, patients with factor XIII<50% had a significantly increased risk of severe upper gastrointestinal bleed, and reduced factor XIII (<50%, 50-75% vs. normal) was associated with increased mortality.
CONCLUSIONS:
Factor XIII deficiency is rare in patients with liver cirrhosis, but is associated with a clinical bleeding tendency and an unfavorable prognosis for future hemorrhages and survival.
AuthorsFrank Tacke, Kai Fiedler, Mario von Depka, Tom Luedde, Hartmut Hecker, Michael P Manns, Arnold Ganser, Christian Trautwein
JournalLiver international : official journal of the International Association for the Study of the Liver (Liver Int) Vol. 26 Issue 2 Pg. 173-81 (Mar 2006) ISSN: 1478-3223 [Print] United States
PMID16448455 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Factor XIII
Topics
  • Adolescent
  • Adult
  • Aged
  • Blood Coagulation Disorders (blood, diagnosis, etiology, mortality)
  • Chronic Disease
  • Factor XIII (metabolism)
  • Female
  • Humans
  • Liver Cirrhosis (blood, complications, diagnosis, mortality)
  • Male
  • Middle Aged
  • Prognosis
  • Proportional Hazards Models
  • Prospective Studies
  • Prothrombin Time (classification)
  • Survival Rate

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: